{"id":10951,"date":"2023-12-05T00:28:00","date_gmt":"2023-12-04T16:28:00","guid":{"rendered":"https:\/\/flcube.com\/?p=10951"},"modified":"2024-11-03T00:30:31","modified_gmt":"2024-11-02T16:30:31","slug":"gedeon-richter-acquires-rights-to-mithras-contraceptive-and-menopause-treatments-for-chinese-market","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=10951","title":{"rendered":"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market"},"content":{"rendered":"\n

Gedeon Richter Plc, a Hungarian pharmaceutical company, and Belgium\u2019s Mithra (OTCMKTS: MITPF<\/a>) have entered into a licensing agreement that grants Gedeon the rights to develop and commercialize two of Mithra\u2019s products in the Chinese market. The products in question are the oral contraceptive Estelle, which contains 15 mg estetrol (E4) \/ 3 mg drospirenone, and the investigational next-generation menopause treatment Donesta, which features estetrol.<\/p>\n\n\n\n

Under the terms of the agreement, Gedeon will pay EUR 4.5 million (USD 4.8 million) upon closing the deal, an additional EUR 1.2 million (USD 1.3 million) for regulatory milestones, and up to EUR 8.5 million (USD 9.2 million) in sales-based milestones, along with royalties on future net sales. The total deal value is estimated at EUR 14.2 million (USD 15.4 million). Gedeon will also be responsible for funding and managing the clinical trials required for the approval of both products in China.<\/p>\n\n\n\n

Mithra specializes in the development of drugs that utilize plant-based estrogen or estetrol. Estelle, the first estetrol-based product, is already commercialized as a combined oral contraceptive in the US and Canada under the brand name Nextstellis, and in Europe by Gedeon Richter as Drovelis. Meanwhile, preparations are underway for an NDA filing for Donesta in the US.- Flcube.com<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Gedeon Richter Plc, a Hungarian pharmaceutical company, and Belgium\u2019s Mithra (OTCMKTS: MITPF) have entered into…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1598,1855,1856],"class_list":["post-10951","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-gedeon-richter","tag-mithra","tag-otcmkts-mitpf"],"yoast_head":"\nGedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Gedeon Richter Plc, a Hungarian pharmaceutical company, and Belgium\u2019s Mithra (OTCMKTS: MITPF) have entered into a licensing agreement that grants Gedeon the rights to develop and commercialize two of Mithra\u2019s products in the Chinese market. The products in question are the oral contraceptive Estelle, which contains 15 mg estetrol (E4) \/ 3 mg drospirenone, and the investigational next-generation menopause treatment Donesta, which features estetrol.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=10951\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=10951\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-04T16:28:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-02T16:30:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=10951#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=10951\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market\",\"datePublished\":\"2023-12-04T16:28:00+00:00\",\"dateModified\":\"2024-11-02T16:30:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=10951\"},\"wordCount\":212,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Gedeon Richter\",\"Mithra\",\"OTCMKTS: MITPF\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=10951#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=10951\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=10951\",\"name\":\"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-12-04T16:28:00+00:00\",\"dateModified\":\"2024-11-02T16:30:31+00:00\",\"description\":\"Gedeon Richter Plc, a Hungarian pharmaceutical company, and Belgium\u2019s Mithra (OTCMKTS: MITPF) have entered into a licensing agreement that grants Gedeon the rights to develop and commercialize two of Mithra\u2019s products in the Chinese market. The products in question are the oral contraceptive Estelle, which contains 15 mg estetrol (E4) \\\/ 3 mg drospirenone, and the investigational next-generation menopause treatment Donesta, which features estetrol.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=10951#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=10951\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=10951#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market - Insight, China's Pharmaceutical Industry","description":"Gedeon Richter Plc, a Hungarian pharmaceutical company, and Belgium\u2019s Mithra (OTCMKTS: MITPF) have entered into a licensing agreement that grants Gedeon the rights to develop and commercialize two of Mithra\u2019s products in the Chinese market. The products in question are the oral contraceptive Estelle, which contains 15 mg estetrol (E4) \/ 3 mg drospirenone, and the investigational next-generation menopause treatment Donesta, which features estetrol.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=10951","og_locale":"en_US","og_type":"article","og_title":"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=10951","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-12-04T16:28:00+00:00","article_modified_time":"2024-11-02T16:30:31+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=10951#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=10951"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market","datePublished":"2023-12-04T16:28:00+00:00","dateModified":"2024-11-02T16:30:31+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=10951"},"wordCount":212,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Gedeon Richter","Mithra","OTCMKTS: MITPF"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=10951#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=10951","url":"https:\/\/flcube.com\/?p=10951","name":"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-12-04T16:28:00+00:00","dateModified":"2024-11-02T16:30:31+00:00","description":"Gedeon Richter Plc, a Hungarian pharmaceutical company, and Belgium\u2019s Mithra (OTCMKTS: MITPF) have entered into a licensing agreement that grants Gedeon the rights to develop and commercialize two of Mithra\u2019s products in the Chinese market. The products in question are the oral contraceptive Estelle, which contains 15 mg estetrol (E4) \/ 3 mg drospirenone, and the investigational next-generation menopause treatment Donesta, which features estetrol.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=10951#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=10951"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=10951#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Gedeon Richter Acquires Rights to Mithra\u2019s Contraceptive and Menopause Treatments for Chinese Market"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/10951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10951"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/10951\/revisions"}],"predecessor-version":[{"id":10952,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/10951\/revisions\/10952"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}